Skip to content

Perioperative Parameter and Treatment Outcomes of ECIRS in Asia

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) in Asia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05894668
Enrollment
1000
Registered
2023-06-08
Start date
2023-08-01
Completion date
2029-03-31
Last updated
2024-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Stone

Brief summary

This is an observational, international, multicenter, cohort study, prospectively collecting clinical data registry on consecutive patients with urinary stone undergoing ECIRS.

Detailed description

Patients diagnosed with urinary stones and planned for ECIRS in different centres will be recruited for the study. This registry collects clinical data on patients with ECIRS performed, includes baseline information on demography, symptoms, risk factors, and laboratory variables. Treatment information, perioperative outcomes, and follow-up details (up to 3 months after surgery) will also be collected. In summary, it captures patterns of presentation and treatment parameters, as well as perioperative and short-term outcomes of patients managed by ECIRS.

Interventions

OTHERECIRS

Endoscopic Combined Intrarenal Surgery

Sponsors

Chinese University of Hong Kong
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Patients with urinary calculi * Undergoing Endoscopic Combined Intrarenal Surgery (ECIRS) * Agreed to consent for the study

Exclusion criteria

* Patients who have ECIRS for other conditions, such as urothelial cancer etc. * Patients who intraoperative record was incomplete. * Patients only have either PCNL or ureteroscopy done (not both)

Design outcomes

Primary

MeasureTime frameDescription
Target Stone statusup to 1 yearThe fragmentation rate of target stone
Treatment related complicationThirty days after the operationhe 30-day complications will be graded according to the Clavien-Dindo classification

Countries

Hong Kong

Contacts

Primary ContactChi Fai NG, MD
ngcf@surgery.cuhk.edu.hk35052625

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026